HYPERHEP
Talecris Biotherapeutics, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78622904 |
| Registration Number | 3225780 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Attorney Name | Maury M. Tepper, III |
| Attorney Docket Number | 54039.0003.8 |
| Law Office Assigned | M70 |
| Employee Name | FRUM MILONE, MARCIE R |
Timeline
| 2005-03-01 | Date of First Use |
| 2005-05-04 | Application Filed |
| 2006-01-24 | Published for Opposition |
| 2007-02-27 | Location: PUBLICATION AND ISSUE SECTION |
| 2007-04-03 | Trademark Registered |
| 2013-11-08 | Cancelled |
| 2013-11-08 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Talecris Biotherapeutics, Inc. |
| Address | 4101 Research Commons, Suite 300 79 T.W. Alexander Drive Research Triangle DE 27709 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | immune globulins |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2005-05-12 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2005-12-01 | 2 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-12-01 | 3 CNSA P: |
| ASSIGNED TO LIE | 2005-12-02 | 4 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2005-12-09 | 5 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2006-01-04 | 6 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2006-01-24 | 7 PUBO A:Allowance for Publication |
| ASSIGNED TO EXAMINER | 2006-02-10 | 8 DOCK D:Assigned to Examiner |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2006-04-18 | 9 NOAM O:Outgoing Correspondence |
| TEAS STATEMENT OF USE RECEIVED | 2006-10-18 | 10 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2006-10-18 | 11 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2006-12-02 | 12 SUPC I:Incoming Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2006-12-27 | 13 ASCK I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2007-01-12 | 14 CNPR P: |
| ASSIGNED TO LIE | 2007-02-17 | 15 ALIE A:Allowance for Publication |
| LAW OFFICE REGISTRATION REVIEW COMPLETED | 2007-02-17 | 16 REGV O:Outgoing Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2007-04-03 | 17 R.PR A:Allowance for Publication |
| CANCELLED SEC. 8 (6-YR) | 2013-11-08 | 18 C8.. O:Outgoing Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2017-02-22 | 19 ASCK I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 HYPERHEP 78622904 3225780 Dead/Cancelled |
Talecris Biotherapeutics, Inc. 2005-05-04 |
 HYPERHEP 73211778 1150184 Dead/Cancelled |
Cutter Laboratories, Inc. 1979-04-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 